响应lysyl氧化酶的定纳米颗粒用于调节瘤免疫微环境
Jinwon Park1, Jung Suk Kim1, Geon Yang1
1College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Republic of Korea.
概括
新的纳米颗粒对瘤中的lysyl氧化酶 (LOX) 产生反应,对原进行定,并使近红外除成为可能. 这种方法调节瘤免疫微环境,增加细胞毒性T细胞,并在临床前模型中改善存活率.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 癌症研究 癌症研究
背景情况:
- lysyl氧化酶 (LOX) 稳定了瘤细胞外基质.
- 瘤微环境的相互作用对于癌症的进展和治疗反应至关重要.
研究的目的:
- 设计和评估用于向药物输送和瘤切除的响应LOX的纳米粒子.
- 研究这些纳米粒子在瘤微环境中的免疫调节作用.
主要方法:
- 开发了可响应LOX.的原蛋白涂层的,含有imiquimod的聚多巴胺纳米颗粒 (CPN/IQ).
- 用LOX分泌CT26细胞进行体外研究,以评估纳米粒子定.
- 在CT26瘤携带小鼠体内研究,以评估抗瘤疗效,免疫调节和存活率.
主要成果:
- CPN/IQ纳米颗粒以LOX-依赖的方式固定在原基质上.
- 单次给予CPN/IQ与近红外辐射导致了原发性瘤消去.
- 在初级瘤中,CPN/IQ治疗减少了调节性T细胞 (Tregs) 和增加了细胞毒性CD3+CD8+T细胞.
- 在瘤再挑战模型中,CPN/IQ治疗增强了脏树突细胞成熟,并促进了长期存活.
结论:
- 响应LOX的纳米粒子提供了一个可行的策略来调节瘤免疫微环境.
- 这种纳米粒子系统显示了向瘤切除和诱导全身抗瘤免疫力的潜力.
- 响应LOX的原基质定纳米颗粒的概念可能适用于各种LOX丰富的瘤类型.
相关概念视频
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Tumor Immunotherapy
573
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
573


